The Case of Fulminant Myocarditis
V. A. Titov,
A. A. Shishkova,
L. B. Mitrofanova,
S. V. Ivanova,
D. A. Zverev,
A. O. Marichev,
O. M. Moiseeva https://doi.org/10.18087/cardio.2019.9.n461
Abstract
Fulminant myocarditis (FM) is a severe form of inflammatory myocardial injury rapidly developing as acute heart failure, cardiogenic shock, or life-threatening disturbances of cardiac rhythm. FM requires intensive treatment including drug therapy, mechanical circulatory support, and in some cases – heart transplantation. Echocardiography can be used as a screening method of diagnostics. Magnetic resonance imaging of the heart often cannot be performed because of hemodynamic instability of a patient, therefore endomyocardial biopsy with histological and immunohistochemical studies as well as molecular-genetic analysis of obtained samples is required for final diagnosis. Prognosis of the disease is determined by histological picture. In most cases, after cessation of acute stage of the inflammatory process, FM has a favorable long-term prognosis. In this article we present a clinical case of FM and review of current literature on diagnosis and treatment of this disease.
About the Authors
V. A. Titov
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Department of non-coronary diseases, postgraduate student
Russian Federation
Department of non-coronary diseases, postgraduate student
A. A. Shishkova
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Cardiologist
Russian Federation
Cardiologist
L. B. Mitrofanova
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Head of the Department of Pathology
Russian Federation
Head of the Department of Pathology
S. V. Ivanova
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Cardiologist
Russian Federation
Cardiologist
D. A. Zverev
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Head of the Department of Interventional Cardiology
Russian Federation
Head of the Department of Interventional Cardiology
A. O. Marichev
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Critical care physician
Russian Federation
Critical care physician
O. M. Moiseeva
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Head of the Department of non-coronary diseases
Russian Federation
Head of the Department of non-coronary diseases
References
1. Montero S, Aissaoui N, Tadié J-M, Bizouarn P, Scherrer V, Persichini R et al. Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. International Journal of Cardiology. 2018;253:105–12. DOI: 10.1016/j.ijcard.2017.10.053
2. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(9995):743–800. DOI: 10.1016/S0140-6736(15)60692-4
3. Cooper LT, Keren A, Sliwa K, Matsumori A, Mensah GA. The Global Burden of Myocarditis. Global Heart. 2014;9(1):121–9. DOI: 10.1016/j.gheart.2014.01.007
4. Maisch B, Ruppert V, Pankuweit S. Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options. Current Heart Failure Reports. 2014;11(2):166–77. DOI: 10.1007/s11897-014-0196-6
5. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathoiogic description of myocarditis. Journal of the American College of Cardiology. 1991;18(7):1617–26. DOI: 10.1016/0735-1097(91)90493-S
6. Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P et al. Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry. Circulation. 2018;138(11):1088–99. DOI: 10.1161/CIRCULATIONAHA.118.035319
7. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A et al. Update on Myocarditis. Journal of the American College of Cardiology. 2012;59(9):779–92. DOI: 10.1016/j.jacc.2011.09.074
8. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34(33):2636–48. DOI: 10.1093/eurheartj/eht210
9. Goitein O, Sabag A, Koperstein R, Hamdan A, Di Segni E, Konen E et al. Role of C reactive protein in evaluating the extent of myocardial inflammation in acute myocarditis. Journal of Cardiovascular Magnetic Resonance. 2015;17(S1):P291. DOI: 10.1186/1532-429X-17-S1-P291
10. Tsai S-H, Chu S-J, Hsu C-W, Cheng S-M, Yang S-P. Use and interpretation of cardiac troponins in the ED. The American Journal of Emergency Medicine. 2008;26(3):331–41. DOI: 10.1016/j.ajem.2007.05.031
11. Mahfoud F, Gartner B, Kindermann M, Ukena C, Gadomski K, Klingel K et al. Virus serology in patients with suspected myocarditis: utility or futility? European Heart Journal. 2011;32(7):897–903. DOI: 10.1093/eurheartj/ehq493
12. Veronese G. Fulminant myocarditis: Characteristics, treatment, and outcomes. The Anatolian Journal of Cardiology. 2018;19(4):279–86. DOI: 10.14744/AnatolJCardiol.2017.8170
13. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2016;18(8):891–975. DOI: 10.1002/ejhf.592
14. Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A et al. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. European Heart Journal. 2005;26(20):2185–92. DOI: 10.1093/eurheartj/ehi411
15. Sawamura A, Okumura T, Ito M, Ozaki Y, Ohte N, Amano T et al. Prognostic Value of Electrocardiography in Patients With Fulminant Myocarditis Supported by Percutaneous Venoarterial Extracorporeal Membrane Oxygenation – Analysis From the CHANGE PUMP Study. Circulation Journal. 2018;82(8):2089–95. DOI: 10.1253/circj.CJ-18-0136
16. Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation. 2002;21(5):516–21. PMID: 11983540
17. Mareev V. Yu., Fomin I. V., Ageev F. T., Begrambekova Yu. L., Vasyuk Yu. A., Garganeeva A. A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(S6):8–164. DOI: 10.18087/cardio.2475
18. Tschöpe C, Kühl U. Myokarditis und entzündliche Kardiomyopathie. DMW - Deutsche Medizinische Wochenschrift. 2016;141(02):95–102. DOI: 10.1055/s-0041-107710
19. Robinson J, Hartling L, Vandermeer B, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database of Systematic Reviews. 2015;5:CD004370. DOI: 10.1002/14651858.CD004370.pub3
20. Kühl U, Schultheiss H-P. Myocarditis: early biopsy allows for tailored regenerative treatment. Deutsches Aerzteblatt Online. 2012;109(20):361–8. DOI: 10.3238/arztebl.2012.0361
21. Chang J-J, Lin M-S, Chen T-H, Chen D-Y, Chen S-W, Hsu J-T et al. Heart Failure and Mortality of Adult Survivors from Acute Myocarditis Requiring Intensive Care Treatment - A Nationwide Cohort Study. International Journal of Medical Sciences. 2017;14(12):1241–50. DOI: 10.7150/ijms.20618
22. Montero S, Aissaoui N, Tadié J-M, Bizouarn P, Scherrer V, Persichini R et al. Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. International Journal of Cardiology. 2018;253:105–12. DOI: 10.1016/j.ijcard.2017.10.053
Review
For citations:
Titov V.A., Shishkova A.A., Mitrofanova L.B., Ivanova S.V., Zverev D.A., Marichev A.O., Moiseeva O.M. The Case of Fulminant Myocarditis. Kardiologiia. 2019;59(9):91-96. (In Russ.) https://doi.org/10.18087/cardio.2019.9.n461
Views:
3818
Email this article 
Post a Comment 
